Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
Clinical trial NCT01336686 · COMPLETED
Trial details
- NCT number
- NCT01336686
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.